Literature DB >> 30804539

Measuring disease activity in SLE is an ongoing struggle.

Anca D Askanase1, Joan T Merrill2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30804539     DOI： 10.1038/s41584-019-0190-1

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN： 1759-4790            Impact factor:   20.543


× No keyword cloud information.
  5 in total

1.  Measurement of circulating CD21-CD27- B lymphocytes in SLE patients is associated with disease activity independently of conventional serological biomarkers.

Authors:  Alice Horisberger; Morgane Humbel; Natalia Fluder; Florence Bellanger; Craig Fenwick; Camillo Ribi; Denis Comte
Journal:  Sci Rep       Date:  2022-06-02       Impact factor: 4.996

2.  Scoring systemic lupus erythematosus (SLE) disease activity with simple, rapid outcome measures.

Authors:  Aikaterini Thanou; Judith A James; Cristina Arriens; Teresa Aberle; Eliza Chakravarty; Joseph Rawdon; Stavros Stavrakis; Joan T Merrill; Anca Askanase
Journal:  Lupus Sci Med       Date:  2019-12-30

3.  LLDAS is an attainable treat-to-target goal in childhood-onset SLE.

Authors:  Mohamed Javad Wahadat; Lotte van den Berg; Demi Timmermans; Kevin van Rijswijk; Annette van Dijk-Hummelman; Susan Bakx; Marleen Verkaaik; Marjan A Versnel; Sylvia Kamphuis
Journal:  Lupus Sci Med       Date:  2021-12

4.  Evaluation of left ventricular systolic function in patients with systemic lupus erythematosus using ultrasonic layer-specific strain technology and its association with cardiovascular events: a long-term follow-up study.

Authors:  Hebin Zhang; Cunxin Yang; Feng Gao; Shanting Hu; Hui Ma
Journal:  Cardiovasc Ultrasound       Date:  2022-10-07       Impact factor: 2.263

5.  A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.

Authors:  Ning-Sheng Lai; Ming-Chi Lu; Hsiu-Hua Chang; Hui-Chin Lo; Chia-Wen Hsu; Kuang-Yung Huang; Chien-Hsueh Tung; Bao-Bao Hsu; Cheng-Han Wu; Malcolm Koo
Journal:  J Clin Med       Date:  2021-05-15       Impact factor: 4.241
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.